Heart reflex test may forecast AFib ablation success
NCT ID NCT04503122
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at 116 people with paroxysmal atrial fibrillation (AFib) who were scheduled for a heart ablation procedure. Researchers measured baroreflex sensitivity—a non-invasive test of the autonomic nervous system—before the procedure. They wanted to see if this measurement could predict whether AFib would come back within a year. The goal is to better understand why AFib returns and to help select patients who are most likely to benefit from ablation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better predict who will benefit most from atrial fibrillation ablation, reducing recurrence rates.
- What could go wrong
- This is an observational study, not a treatment trial. The results may not lead to immediate changes in clinical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAROXYSMAL ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Poitiers
Poitiers, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a bigger balloon tame the Heart's electrical chaos?
- Can a new heart ablation technique work without x-rays?
- Could a gentle sedation cocktail replace general anesthesia for heart ablation?
- Can a new freezing balloon tame a fluttering heart as well as the old one?
- Heart signals may reveal if a common AFib procedure will last
- Zapping the heart back to rhythm: a new device uses pulsed fields to treat atrial fibrillation